KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Liabilities (2016 - 2025)

Edwards Lifesciences has reported Total Liabilities over the past 17 years, most recently at $3.4 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $3.4 billion for Q4 2025, up 12.27% from a year ago — trailing twelve months through Dec 2025 was $3.4 billion (up 12.27% YoY), and the annual figure for FY2025 was $3.4 billion, up 12.27%.
  • Total Liabilities for Q4 2025 was $3.4 billion at Edwards Lifesciences, up from $3.1 billion in the prior quarter.
  • Over the last five years, Total Liabilities for EW hit a ceiling of $3.4 billion in Q3 2024 and a floor of $2.4 billion in Q3 2022.
  • Median Total Liabilities over the past 5 years was $2.6 billion (2021), compared with a mean of $2.7 billion.
  • Biggest five-year swings in Total Liabilities: rose 27.09% in 2024 and later fell 8.71% in 2025.
  • Edwards Lifesciences' Total Liabilities stood at $2.7 billion in 2021, then fell by 6.78% to $2.5 billion in 2022, then grew by 6.36% to $2.6 billion in 2023, then grew by 13.19% to $3.0 billion in 2024, then increased by 12.27% to $3.4 billion in 2025.
  • The last three reported values for Total Liabilities were $3.4 billion (Q4 2025), $3.1 billion (Q3 2025), and $2.9 billion (Q2 2025) per Business Quant data.